Legend Biotech 1 article

Legend Biotech is a cell-therapy biotechnology company whose scientific identity centers on cell therapy, with BCMA-directed CAR-T therapy defining how the therapeutic cells are selected or engineered. A further part of its cellular strategy is autologous CAR-T cell therapy, complemented by multiple myeloma cellular immunotherapy; chimeric antigen receptor T cells supplies the disease or manufacturing context for those engineered cells. GenoMethods keeps the cell-therapy modality and individual cellular products separate; the platform identity of Legend Biotech also includes hematologic malignancy cell therapy.

Clinical Trials & Evidence

September 25, 2026, 1:45 PM · 6 mins read

Cilta-cel moves up in multiple myeloma as CAR T first strategy gains ground

Doctors are pushing to use ciltacabtagene autoleucel earlier in multiple myeloma. The debate now centers on when to give CAR T, how to refer patients, and what a functional cure really means.